Active Funding Opportunity Announcements (FOAs) for All NICHD

NICHD issues and participates in various FOAs to support research activities and training.

Investigator-Initiated (Unsolicited) Projects

To submit unsolicited or investigator-initiated applications, use the appropriate NIH Parent Announcement.

Active FOAs for NICHD

Please note: The following FOAs are sorted by date, from most recent to oldest. Select a table heading to change how to sort and display the FOAs.

Announcement Number Submissions Date(s) Expiration Date Activity Code(s) Title
PAR-20-031 December 20, 2019; November 30, 2020; November 30, 2021 December 21, 2021 R01 Human-Animal Interaction (HAI) Research (R01 Clinical Trial Optional)
PAR-20-032 December 20, 2019; November 30, 2020; November 30, 2021 December 21, 2021 R03 Human-Animal Interaction (HAI) Research (R03 Clinical Trial Optional)
PAR-20-033 December 20, 2019; November 30, 2020; November 30, 2021 December 21, 2021 R21 Human-Animal Interaction (HAI) Research (R21 Clinical Trial Optional)
RFA-HD-20-002 Only accepting applications for the AIDS Application Due Date(s) listed below. December 6, 2019 P01 Pediatric HIV/AIDS Cohort Study (PHACS) 2020 (P01 Clinical Trial Not Allowed)
RFA-NS-20-010 January 8, 2020, April 7, 2020, September 9, 2020, January 6, 2021, April 6, 2021, September 8, 2021, January 6, 2022, April 6, 2022, and September 8, 2022 September 9, 2022 R43/R44 HEAL INITIATIVE: Development of Therapies and Technologies Directed at Enhanced Pain Management (R43/R44 - Clinical Trial Required)
RFA-NS-20-011 January 8, 2020, April 7, 2020, September 9, 2020, January 6, 2021, April 6, 2021, September 8, 2021, January 6, 2022, April 6, 2022, and September 8, 2022 September 9, 2022 R43/R44 HEAL INITIATIVE: Development of Therapies and Technologies Directed at Enhanced Pain Management (R43/R44 - Clinical Trial Not Allowed)
RFA-NS-20-008 January 8, 2020, April 7, 2020, September 9, 2020, January 6, 2021, April 6, 2021, September 8, 2021, January 6, 2022, April 6, 2022, and September 8, 2022 September 9, 2022 R41/R42 HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R41/R42 Clinical Trial Required)
RFA-NS-20-009 January 8, 2020, April 7, 2020, September 9, 2020, January 6, 2021, April 6, 2021, September 8, 2021, January 6, 2022, April 6, 2022, and September 8, 2022 September 9, 2022 R41/R42 HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R41/R42 Clinical Trial Not Allowed)
RFA-HD-20-013 November 29, 2019

All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s).

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
November 30, 2019 K12 Womens Reproductive Health Research (WRHR) Career Development Program (K12 Clinical Trial Optional)
RFA-MD-20-001 November 22, 2019

All applicants are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
November 23, 2019 P50 Limited Competition: Specialized Centers of Excellence on Environmental Health Disparities Research (P50)
RFA-NS-20-003 December 16, 2019.
No late applications will be accepted for this Funding Opportunity Announcement.
All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
December 17, 2019 R25 NIH Blueprint for Neuroscience Research Education Program on Translational Devices (R25 Clinical Trial Not Allowed)
PAR-19-384 March 17, 2020; March 17, 2021 March 18, 2021 R01 Research on biopsychosocial factors of social connectedness and isolation on health, wellbeing, illness, and recovery (R01 Basic Experimental Studies with Humans Required)
PAR-19-373 March 17, 2020; March 17, 2021, March 18, 2021 R01 Research on biopsychosocial factors of social connectedness and isolation on health, wellbeing, illness, and recovery (R01 Clinical Trials Not Allowed)
RFA-HD-20-019 December 10, 2019, by 5:00 PM local time of applicant organization.
No late applications will be accepted for this Funding Opportunity Announcement
December 11, 2019 R43/R44 Non-invasive Diagnostics to Improve Gynecologic Health (R43/R44 Clinical Trial Optional)
RFA-HD-20-008 December 2, 2019 December 3, 2019 R61/R33 Innovative Epidemiologic Approaches for Understanding Long-term Health Outcomes of HIV-exposed Uninfected (HEU) Populations (R61/R33 Clinical Trial Not Allowed)
PAR-19-376 November 19, 2019; September 24, 2020 December 4, 2020 R21/R33 Mobile Health: Technology and Outcomes in Low and Middle Income Countries (R21/R33 - Clinical Trial Optional)
PAR-19-375 Standard dates apply ,
The first standard application due date for this FOA is February 16, 2020..
January 8, 2023 R03 Small Research Grants for Analyses of Gabriella Miller Kids First Pediatric Research Data (R03 Clinical Trial Not Allowed)
RFA-HD-20-001 November 29, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. November 30, 2019 R24 Data Sharing for Demographic Research Infrastructure Program (R24 Clinical Trial Not Allowed)
RFA-HD-20-021 November 26, 2019 November 27, 2019 R21 Fertility and Fertility Preservation for Patients with Diseases that Previously Precluded Reproduction (R21 Clinical Trial Optional)
RFA-HD-20-020 November 1, 2019 November 2, 2019 R21 Using Archived Data and Specimen Collections to Advance Maternal and Pediatric HIV/AIDS Research (R21 Clinical Trial Not Allowed)
top of pageBACK TO TOP